Cumberland Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,416.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.6 | 2.7 | 3.2 | 3.1 | 2.9 | 2.8 | 2.6 | 2.3 | 2.3 | 2.3 | 2.1 | 2.2 | 1.9 | 1.7 | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.9 | 1.1 | 0.8 | 0.8 | 0.8 | 0.7 | 0.5 | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.9 | 1.6 | 1.2 | 1.1 | 1.3 | 1.2 | 3.1 | |
| 1.1 | 1.2 | 1.5 | 1.7 | 1.7 | 1.8 | 1.7 | 1.6 | 1.5 | 1.7 | 1.7 | 1.8 | 1.8 | 1.5 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 1.6 | 1.0 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 | 0.8 | 0.9 | 0.9 | 0.8 | 0.7 | 1.5 | 2.2 | 1.8 | 1.8 | 2.4 | 2.3 | 5.6 | |
| 1.6 | 1.9 | 2.3 | 2.5 | 2.2 | 2.2 | 2.3 | 2.0 | 1.6 | 2.1 | 2.0 | 2.2 | 1.8 | 1.5 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 0.8 | 0.8 | 1.6 | 1.2 | 0.8 | 0.8 | 0.7 | 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.5 | 0.5 | 0.8 | 1.3 | 1.0 | 0.9 | 1.2 | 1.1 | 3.0 | |
| 22.7 | 53.5 | 74.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,440.5 | 13.4 | 16.1 | – | – | – | – | 89.3 | 16.6 | 4.4 | 6.9 | 23.5 | – | – | – | 171.0 | 16.8 | 11.6 | 13.7 | 20.1 | – | – | |
| – | – | – | – | – | – | – | 388.5 | – | – | – | – | 35.3 | 38.9 | 17.9 | 12.1 | 14.5 | 13.0 | 9.5 | 9.0 | 8.3 | 11.5 | 9.7 | 8.3 | 5.5 | 5.2 | 5.9 | 2.7 | 4.1 | 4.5 | 4.8 | – | – | – | 12.0 | 7.2 | 6.9 | 12.5 | 37.4 | – | |
| -1.0% | -1.8% | -0.5% | -1.7% | -0.7% | -1.8% | -3.1% | 0.3% | -3.5% | -1.2% | -1.7% | -0.5% | 2.8% | 2.6% | 5.6% | 8.3% | 6.9% | 7.7% | 10.5% | 11.2% | 12.0% | 8.7% | 10.3% | 12.0% | 18.1% | 19.3% | 17.1% | 36.5% | 24.6% | 22.1% | 21.0% | -4.7% | -8.9% | -2.1% | 8.3% | 13.9% | 14.5% | 8.0% | 2.7% | -1.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 81.4% | 82.0% | 82.5% | 81.7% | 82.3% | 82.1% | 81.3% | 82.3% | 82.9% | 81.9% | 82.2% | 81.7% | 81.4% | 81.6% | 80.9% | 78.6% | 77.5% | 76.9% | 76.2% | 78.1% | 79.6% | 75.5% | 76.5% | 76.5% | 76.2% | 78.3% | 79.6% | 81.2% | 81.7% | 84.7% | 83.5% | 82.6% | 83.3% | 82.6% | 84.3% | 84.0% | 84.5% | 85.0% | 82.9% | 83.4% | |
| -2.0% | -4.3% | -4.6% | -8.8% | -10.7% | -9.9% | -14.7% | -12.2% | -15.5% | -18.1% | -11.6% | -10.7% | -10.3% | -7.6% | -12.0% | -14.9% | -13.8% | -17.0% | -12.3% | -12.1% | -13.4% | -21.3% | -23.6% | -23.9% | -18.9% | -13.6% | -14.8% | -10.0% | -14.4% | -24.2% | -25.5% | -29.0% | -29.3% | -17.0% | -8.0% | -7.1% | -7.9% | -6.3% | -17.2% | -30.8% | |
| -0.1% | -2.9% | -5.6% | -19.6% | -20.5% | -19.4% | -22.7% | -11.2% | -14.3% | -17.1% | -10.6% | -9.9% | -10.1% | -7.4% | -10.3% | -11.6% | -8.4% | -8.9% | -5.3% | 0.1% | -1.4% | -9.7% | -13.8% | -20.1% | -16.9% | -13.3% | -10.0% | -4.4% | -6.2% | -15.9% | -21.7% | -27.5% | -29.6% | -17.1% | -8.0% | -7.0% | -8.1% | -6.4% | -17.2% | -33.9% | |
| -2.5% | -4.7% | -1.7% | -5.1% | -2.0% | -5.0% | -8.2% | 0.6% | -8.0% | -2.9% | -3.5% | -1.1% | 5.4% | 4.3% | 7.1% | 9.9% | 8.2% | 9.3% | 12.2% | 12.1% | 12.7% | 16.9% | 11.5% | 9.8% | 15.2% | 15.2% | 12.4% | 19.6% | 17.0% | 14.3% | 13.0% | -2.7% | -4.4% | -1.9% | 13.0% | 16.8% | 16.2% | 10.7% | 3.1% | -3.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -0.1% | -1.3% | -2.7% | -10.6% | -12.2% | -12.4% | -14.9% | -7.8% | -9.5% | -12.5% | -8.4% | -8.3% | -9.3% | -6.9% | -9.1% | -10.1% | -7.1% | -7.1% | -4.5% | 0.1% | -1.2% | -8.2% | -12.3% | -19.3% | -18.0% | -15.4% | -11.0% | -4.8% | -6.7% | -21.2% | -30.6% | -39.4% | -43.9% | -28.4% | -11.4% | -10.5% | -12.7% | -11.4% | -33.4% | -60.8% | |
| 0.0% | -1.0% | -2.1% | -8.1% | -8.8% | -8.6% | -10.0% | -5.1% | -6.3% | -6.2% | -4.1% | -4.2% | -4.6% | -3.4% | -4.6% | -5.0% | -3.6% | -3.5% | -2.3% | 0.0% | -0.6% | -4.2% | -5.2% | -8.2% | -7.7% | -6.0% | -4.5% | -2.0% | -2.8% | -7.7% | -10.3% | -13.2% | -14.2% | -8.6% | -4.7% | -4.3% | -5.1% | -3.7% | -10.2% | -16.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -32 | -26 | -31 | -21 | -26 | -26 | -11 | -12 | -26 | -7.9 | -3.6 | -1.0 | -7.0 | -8.8 | -7.6 | -9.4 | -8.7 | -6.5 | -8.9 | -11 | -9.7 | -11 | 3.5 | 1.3 | -1.6 | -3.4 | -0.2 | -4.8 | -5.3 | -5.2 | -2.1 | -0.9 | -1.0 | -2.3 | -9.5 | -10 | -9.6 | -5.7 | -5.3 | -3.4 | |
| -14.3 | -22.5 | -29.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -588.1 | -4.5 | -5.1 | – | – | – | – | -10.2 | -0.1 | -1.2 | -1.7 | -6.0 | – | – | – | -12.8 | -2.9 | -3.0 | -3.6 | -2.1 | – | – | |
| 81.8% | 78.4% | 78.8% | 75.9% | 72.0% | 68.8% | 67.1% | 66.2% | 66.6% | 49.6% | 48.4% | 50.3% | 49.9% | 48.9% | 51.2% | 49.7% | 49.9% | 48.7% | 50.4% | 54.0% | 53.5% | 50.7% | 42.4% | 42.7% | 42.7% | 39.0% | 40.6% | 41.6% | 41.0% | 36.2% | 33.7% | 33.6% | 32.3% | 30.2% | 41.0% | 41.2% | 39.6% | 32.4% | 30.5% | 27.7% | |
| 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | 0.7 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 0.00 | -0.06 | -0.12 | -0.44 | -0.50 | -0.51 | -0.58 | -0.30 | -0.36 | -0.45 | -0.29 | -0.29 | -0.31 | -0.23 | -0.29 | -0.32 | -0.23 | -0.22 | -0.14 | 0.00 | -0.04 | -0.24 | -0.34 | -0.52 | -0.48 | -0.39 | -0.27 | -0.12 | -0.17 | -0.44 | -0.60 | -0.73 | -0.77 | -0.46 | -0.21 | -0.20 | -0.22 | -0.19 | -0.48 | -0.71 | |
| 1.94 | 2.05 | 2.18 | 2.26 | 2.43 | 2.62 | 2.56 | 2.65 | 2.50 | 2.62 | 2.77 | 2.93 | 3.08 | 3.12 | 2.82 | 2.75 | 2.70 | 2.49 | 2.60 | 2.59 | 2.55 | 2.43 | 2.49 | 2.58 | 2.85 | 2.92 | 2.75 | 2.79 | 2.75 | 2.79 | 2.75 | 2.68 | 2.62 | 2.71 | 2.69 | 2.81 | 2.76 | 2.98 | 2.80 | 2.09 | |
| 4.52 | 4.54 | 4.51 | 4.16 | 4.10 | 4.08 | 3.89 | 3.82 | 3.74 | 3.60 | 3.49 | 3.48 | 3.37 | 3.36 | 3.20 | 3.18 | 3.17 | 3.13 | 3.08 | 3.17 | 3.15 | 2.89 | 2.79 | 2.69 | 2.68 | 2.52 | 2.49 | 2.55 | 2.52 | 2.09 | 1.95 | 1.87 | 1.76 | 1.64 | 1.88 | 1.87 | 1.75 | 1.66 | 1.45 | 1.16 | |
| -0.05 | -0.10 | -0.04 | -0.12 | -0.05 | -0.13 | -0.21 | 0.02 | -0.20 | -0.07 | -0.10 | -0.03 | 0.17 | 0.13 | 0.20 | 0.27 | 0.22 | 0.23 | 0.32 | 0.31 | 0.32 | 0.41 | 0.29 | 0.25 | 0.43 | 0.44 | 0.34 | 0.55 | 0.47 | 0.40 | 0.36 | -0.07 | -0.12 | -0.05 | 0.35 | 0.47 | 0.45 | 0.32 | 0.09 | -0.07 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.